Neuren Pharmaceuticals | NEU - Pre Tax Profit

Stock Price
12.52
Daily Change
-0.68 -5.15%
Monthly
-31.51%
Yearly
-10.70%
Q1 Forecast
16.35

Neuren Pharmaceuticals reported AUD9.86M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -23.77M 12.2M Jun/2025
Clinuvel Pharmaceuticals AUD 35.87M 21.07M Jun/2024
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Genetic Signatures AUD -2.45M 2.08M Jun/2025
Ionis Pharmaceuticals USD -129M 253M Sep/2025
Medical Developments International AUD -149K 466K Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organon & Co USD 243M 14M Sep/2025
PYC Therapeutics AUD -12.57M 13.3M Jun/2025
Starpharma Holdings AUD -2.3M 1.94M Jun/2025
Tectonic Therapeutic USD -19.04M 25K Sep/2025
Telix Pharmaceuticals AUD 76.73M 66.04M Jun/2025
Viatris USD -7.9M 209.2M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025